{
    "nct_id": "NCT04920097",
    "official_title": "Auricular Point Acupressure to Manage Chemotherapy Induced Neuropathy",
    "inclusion_criteria": "* cancer patients ages ≥18 years\n* have received a medication in one of the following categories: platinum-based, vinca alkaloids, bortezomib, eribulin, and/or taxanes\n* have CIN due to receiving neurotoxic chemotherapy for cancer or have pre-existing peripheral neuropathy of another etiology that worsened after chemotherapy\n* have one of the average intensity of pain, or numbness, or tingling on their extremities the previous week due to CIN ≥ 4 on a 11-point numerical scale.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "* use of an investigational agent for pain control concurrently or within the past 30 days\n* use of an implantable drug delivery system, e.g. Medtronic SynchroMed®\n* prior celiac plexus block or other neurolytic pain control treatment\n* other identified causes of painful paresthesia existing prior to chemotherapy (e.g., radiation or malignant plexopathy, lumbar or cervical radiculopathy,)\n* allergy to latex (the tapes for the APA include latex) and/or having a history of allergic reactions to the adhesive tape\n* pregnant women (based on the self-reported data)\n* individuals diagnosed with diabetic neuropathy",
    "miscellaneous_criteria": ""
}